Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 2,858
- Total 13F value
- $93,514
- Share change
- +426
- SEC-reported price per share
- $32.72
- Number of holders
- 3
- Value change
- +$13,939
- Number of buys
- 3
- Shares outstanding
- 58,810,778
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
3
Top holders
3
STOK full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Ownership snapshot
Top reported holders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
13D/G row: RTW INVESTMENTS, LP
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
9.9%
FMR LLC
9.8%
Lynx1 Capital Management LP
8.1%
BlackRock, Inc.
6.8%
Redmile Group, LLC
6.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13D/G
13F
Company
|
9.9%
|
$208,227,353
5,940,866 shares
|
+$22,110,697 | 31 Mar 2026 |
| FMR LLC |
13D/G
13F
Company
|
9.8%
|
$177,773,201
5,600,920 shares
|
-$40,123,708 | 31 Dec 2025 |
| Lynx1 Capital Management LP |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$155,105,193
4,763,673 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.8%
from 13D/G
|
$175,358,848
5,385,714 shares
|
— | 31 Mar 2026 |
| Redmile Group, LLC |
13D/G
13F
Company
|
6.7%
|
$145,952,406
4,164,120 shares
|
-$7,423,976 | 31 Mar 2026 |
| MORGAN STANLEY |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$111,461,996
3,423,280 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
2,858
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
195
Q2 2026 holders
3
Holder diff
-192
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend